pharmaceutical investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
pharmaceutical investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
pharmaceutical investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
pharmaceutical investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
pharmaceutical investing Corbus Pharmaceuticals Reports 2017 Financial Results and Provides Clinical Update
pharmaceutical investing Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
Moleculin Announces Collaboration with Emory University to Develop Novel Treatment of Pediatric Brain Cancer
